Viral Hepatitis
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2005; 11(46): 7302-7307
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7302
Table 1 Characteristics of studies included in the meta-analysis
First author(year)[reference]Country(ethnicity)SpontaneousresolutionPersistentinfectionMatchingAnti-HCV testsHLA typing
Alric (1997)France (European)25, M/F: 9/16103, M/F: 58/45Sex, age, source of HCV infection, HCV-serotype2G EIA and RIBAPCR-SSOP
[21]Age: 40.6±15.7 yrAge: 45.4±12.4 yr
Cramp (1998)UK (European)49, M/F: 30/1955, M/F: 31/24Sex, age, source of HCV infection and duration2G line immunoassayPCR-SSOP
[22]Duration: 15.5 (3-42) yrDuration: 14.2 (2-40) yr
Minton (1998)UK (European)35, M/F: 19/16138, M/F: 87/51Sex, age, source of HCV infection2G ELISA and RIBAPCR-SSOP
[23]Age: 37.9±10.8 yrAge: 37.2±10.1 yr
Mangia (1999)Italy (European)35149Sex, HCV-serotype, not age,RIBA and 3G EIAPCR-SSP
[24]not duration
Thursz (1999)European85, M/F: 37/48170, M/F: 74/96Sex, center, not ageELISA and RIBAPCR-SSP
[25]Age: 45±14 yrAge: 50±16 yr
Vejbaesya (2000)Thailand (Asian)43 Blood donor57Sex2G EIA and RIBAPCR-SSOP
[26]M/F: 25/18M/F: 31/18
Alric (2000)France (European)63, M/F: 21/42282, M/F: 150/132Age, source of HCV infection and duration, not sex2G EIA and RIBAPCR-SSOP
[27]Age: 42.1±15.4 yrAge: 46±12.3 yr
Fanning (2000)Irish (European)85 Female72 FemaleFrom single sourceRIBAReverse line probe hybridization
[13]
Thio (2001)North America200, M/F: 166/34374, M/F: 310/64Age, sex, race2G EIA and RIBAPCR-SSP PCR-SSCP
[28]Age: 25.7 yrAge: 27.8 yr
Azocar (2003)Hispanic (European)40,M/F: 33/772, M/F: 54/18Age, sexEIA and RIBAPCR-SSOP PCR-SSP
[29]Age: 37.9 yrAge: 39.2 yr
Spada (2004)Italy (European)10, M/F: 5/524,M/F:22/2Not sex, age, source of HCV infection, HCV-serotype3G ELISA and RIBAPCR-SSP
[30]Age: 40.5 (20-61) yrAge: 29 (20-56) yr